ResearcherUniversity of BernActive in the last 2 years
Pauline Aeschbacher
Matched on ORCID iD 0000-0002-8033-4179; OpenAlex author ID A5057374206. Sources: OpenAlex.
Their work
- Papers
- 7
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2023: 2 papers · 2024: 1 paper · 2025: 2 papers · 2026: 2 papers
Papers 7
- RNF43 Mutations Are Associated With the Classical Molecular Subtype, Vigorous Antitumor Immune Responses, and Prolonged Survival in Pancreatic Adenocarcinoma. Co-author DOI 10.1016/j.modpat.2026.101010↗
- ASO Visual Abstract: Initiation and Completion of Adjuvant Chemotherapy After Total versus Partial Pancreaticoduodenectomy for Pancreatic Cancer. Co-author DOI 10.1245/s10434-025-18579-w↗
- Initiation and Completion of Adjuvant Chemotherapy After Total Versus Partial Pancreaticoduodenectomy for Pancreatic Cancer. Co-author DOI 10.1245/s10434-025-18378-3↗
- Impact of Routine and Selective Preoperative Endoscopic Retrograde Cholangiopancreatography with Stent Placement on Postoperative and Oncologic Outcomes Follow… Co-author DOI 10.3390/biomedicines13020333↗
- Spatial Heterogeneity of Immune Regulators Drives Dynamic Changes in Local Immune Responses, Affecting Disease Outcomes in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-24-0368↗
- Resection margin status at the portomesenteric axis may not determine oncologic outcome after pancreaticoduodenectomy for lymph node-positive pancreatic ductal… Co-author DOI 10.1016/j.surg.2023.03.007↗
- Spatially restricted tumour-associated and host-associated immune drivers correlate with the recurrence sites of pancreatic cancer. Co-author DOI 10.1136/gutjnl-2022-329371↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Anna Silvia Wenning · 7 shared papers, 2023–2026 · strength 1.72
- Paper RNF43 Mutations Are Associated With the Classical Molecular Subtype, Vigorous Antitumor Immune Responses, and Prolonged… DOI 10.1016/j.modpat.2026.101010↗
- Paper ASO Visual Abstract: Initiation and Completion of Adjuvant Chemotherapy After Total versus Partial Pancreaticoduodenect… DOI 10.1245/s10434-025-18579-w↗
- Paper Initiation and Completion of Adjuvant Chemotherapy After Total Versus Partial Pancreaticoduodenectomy for Pancreatic Ca… DOI 10.1245/s10434-025-18378-3↗
- Beat Gloor · 7 shared papers, 2023–2026 · strength 1.72
- Paper RNF43 Mutations Are Associated With the Classical Molecular Subtype, Vigorous Antitumor Immune Responses, and Prolonged… DOI 10.1016/j.modpat.2026.101010↗
- Paper ASO Visual Abstract: Initiation and Completion of Adjuvant Chemotherapy After Total versus Partial Pancreaticoduodenect… DOI 10.1245/s10434-025-18579-w↗
- Paper Initiation and Completion of Adjuvant Chemotherapy After Total Versus Partial Pancreaticoduodenectomy for Pancreatic Ca… DOI 10.1245/s10434-025-18378-3↗
- Andréas Andreou · 4 shared papers, 2023–2026 · strength 0.96
- Paper ASO Visual Abstract: Initiation and Completion of Adjuvant Chemotherapy After Total versus Partial Pancreaticoduodenect… DOI 10.1245/s10434-025-18579-w↗
- Paper Initiation and Completion of Adjuvant Chemotherapy After Total Versus Partial Pancreaticoduodenectomy for Pancreatic Ca… DOI 10.1245/s10434-025-18378-3↗
- Paper Impact of Routine and Selective Preoperative Endoscopic Retrograde Cholangiopancreatography with Stent Placement on Pos… DOI 10.3390/biomedicines13020333↗
- Aurel A. Perren · 3 shared papers, 2023–2026 · strength 0.77
- Paper RNF43 Mutations Are Associated With the Classical Molecular Subtype, Vigorous Antitumor Immune Responses, and Prolonged… DOI 10.1016/j.modpat.2026.101010↗
- Paper Spatial Heterogeneity of Immune Regulators Drives Dynamic Changes in Local Immune Responses, Affecting Disease Outcomes… DOI 10.1158/1078-0432.ccr-24-0368↗
- Paper Spatially restricted tumour-associated and host-associated immune drivers correlate with the recurrence sites of pancre… DOI 10.1136/gutjnl-2022-329371↗
- Animesh Acharjee · 3 shared papers, 2023–2026 · strength 0.77
- Paper RNF43 Mutations Are Associated With the Classical Molecular Subtype, Vigorous Antitumor Immune Responses, and Prolonged… DOI 10.1016/j.modpat.2026.101010↗
- Paper Spatial Heterogeneity of Immune Regulators Drives Dynamic Changes in Local Immune Responses, Affecting Disease Outcomes… DOI 10.1158/1078-0432.ccr-24-0368↗
- Paper Spatially restricted tumour-associated and host-associated immune drivers correlate with the recurrence sites of pancre… DOI 10.1136/gutjnl-2022-329371↗
- Eva Karamitopoulou · 3 shared papers, 2023–2026 · strength 0.77
- Paper RNF43 Mutations Are Associated With the Classical Molecular Subtype, Vigorous Antitumor Immune Responses, and Prolonged… DOI 10.1016/j.modpat.2026.101010↗
- Paper Spatial Heterogeneity of Immune Regulators Drives Dynamic Changes in Local Immune Responses, Affecting Disease Outcomes… DOI 10.1158/1078-0432.ccr-24-0368↗
- Paper Spatially restricted tumour-associated and host-associated immune drivers correlate with the recurrence sites of pancre… DOI 10.1136/gutjnl-2022-329371↗
- Romy Weber · 2 shared papers, 2025–2026 · strength 0.53
- Paper ASO Visual Abstract: Initiation and Completion of Adjuvant Chemotherapy After Total versus Partial Pancreaticoduodenect… DOI 10.1245/s10434-025-18579-w↗
- Paper Initiation and Completion of Adjuvant Chemotherapy After Total Versus Partial Pancreaticoduodenectomy for Pancreatic Ca… DOI 10.1245/s10434-025-18378-3↗
- Martin D. Berger · 2 shared papers, 2025–2026 · strength 0.53
- Paper ASO Visual Abstract: Initiation and Completion of Adjuvant Chemotherapy After Total versus Partial Pancreaticoduodenect… DOI 10.1245/s10434-025-18579-w↗
- Paper Initiation and Completion of Adjuvant Chemotherapy After Total Versus Partial Pancreaticoduodenectomy for Pancreatic Ca… DOI 10.1245/s10434-025-18378-3↗
- Shadi Katou · 2 shared papers, 2023–2025 · strength 0.42
- Paper Impact of Routine and Selective Preoperative Endoscopic Retrograde Cholangiopancreatography with Stent Placement on Pos… DOI 10.3390/biomedicines13020333↗
- Paper Resection margin status at the portomesenteric axis may not determine oncologic outcome after pancreaticoduodenectomy f… DOI 10.1016/j.surg.2023.03.007↗
- Benjamin Struecker · 2 shared papers, 2023–2025 · strength 0.42
- Paper Impact of Routine and Selective Preoperative Endoscopic Retrograde Cholangiopancreatography with Stent Placement on Pos… DOI 10.3390/biomedicines13020333↗
- Paper Resection margin status at the portomesenteric axis may not determine oncologic outcome after pancreaticoduodenectomy f… DOI 10.1016/j.surg.2023.03.007↗
- Konstantin Bräutigam · 1 shared paper, 2026 · strength 0.33
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.